HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
Cell and Gene Therapy Collaborative News & Announcements
Displaying announcements from the past three years.
1 - 12 of 12
Published on Aug 31, 2023 in Cornerstone Blog
Children’s Hospital of Philadelphia is the lead study site for the development of a gene therapy for multiple sulfatase deficiency.
Published on May 12, 2023 in Cornerstone Blog
Learn about a novel disorder caused by rare genetic variants, the importance of global neonatal outcomes, and more, in this week’s edition of In the News.
Published on May 2, 2023 in Cornerstone Blog
This month’s Featured Research Trainee for Asian American and Pacific Islander Heritage Month is Huijie (Jade) Feng, PhD
Published on Apr 17, 2023 in Announcements
The Master of Regulatory Affairs program is accepting applications for the Fall 2023 academic year.
Published on Feb 22, 2023 in Cornerstone Blog
Cassie Kline, MD, MAS, and Jessica Foster, MD, received a seed grant to study CAR T-cell and radiotherapy for diffuse midline gliomas.
Published on Feb 6, 2023 in Cornerstone Blog
Two scientists with unique skill sets are developing an alternative method for gene therapy delivery with support from a CGTC Seed Grant.
Published on Jan 19, 2023 in Cornerstone Blog
In this Q&A, Drs. Teachey and Diorio discuss their partnership and research of a novel CAR T-cell therapy for one of the most common pediatric cancers.
Published on Sep 9, 2022 in Cornerstone Blog
In this Q&A, hematologist Dr. Kwiatkowski discusses the Food and Drug Administration approval of beti-cel (Zynteglo®), a gene therapy for beta thalassemia.
Published on Dec 1, 2021 in Press Releases
Next-generation DNA sequencing can predict relapse of patients with acute lymphoblastic leukemia treated with (CAR) T-cell therapy.
Published on Nov 3, 2021 in Press Releases
CHOP researchers have developed a novel cancer therapy that targets proteins inside cancer cells that are essential for tumor growth.
Published on Nov 3, 2021 in Cornerstone Blog
The peptide-centric CAR T cells, or PC-CARS, target cancer drivers in tumor cells previously thought unreachable.
Published on Aug 10, 2021 in Press Releases
CHOP researchers presented preliminary data that CRISPR therapy for inherited blood disorders is safe and effective.